Dr. Jison Hong

Rheumatologist focused on gout and complex inflammatory conditions

Gout • hyperuricemia • granulomatous mastitis • healthcare access for Asian American Native Hawaiian and Pacific Islander communities • value-based care

1Episode

59 minAnalysed

1Topic

Last reviewed: Jun 9, 2026·Credential: MD; Internal Medicine residency Rutgers New Jersey Medical School; Immunology & Rheumatology fellowship Stanford University Medical Center; Stanford Health Care clinician; Stanford CARE affiliate.·First indexed: Jun 9, 2026

About the expert

Focus: Gout in Asian populations and value-based rheumatology care

Rheumatologist at Stanford with affiliations to the Stanford Center for Asian Health Research and Education (CARE). Specializes in the diagnosis and management of all rheumatologic diseases with particular interest in complex gout and granulomatous mastitis. Involved in research identifying healthcare access barriers for Asian American Native Hawaiian and Pacific Islander communities. Serves as the division champion for Stanford's Value Based Care Program.

Why this matters

Researcher at Stanford Center for Asian Health Research and Education (CARE) focused on chronic disease management in Asian-American populations. Tends to advocate for population-specific tailoring of universal frameworks, with explicit attention to genetics, cultural diet, and care-access barriers. Strongest on Asian-American gout patterns and culturally-grounded clinical care; less involved in non-population-specific rheumatology research or broader autoimmune disease.

Filter by species:

Topics covered

Gout (Human)

Episodes with Dr. Jison Hong

Hong on gout in the Asian population: genetics, diet, and clinical care gaps

Gout patterns, genetic susceptibility, and treatment response differ in Asian populations compared to the historical Western clinical literature. Specific genetic variants in uric acid transport (such as the SLC2A9 and ABCG2 genes) are more common in some Asian populations and increase gout risk. Cultural dietary factors and language or care-access barriers can compound the clinical picture. Standard treat-to-target principles still apply, but clinician awareness of these population-specific patterns matters for accurate diagnosis and effective long-term management.

59 minHuman

Explore episode →